Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker PCRX
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Vanguard Capital Management | 1.92M | 4.8% | SCHEDULE 13G/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA2 LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | The John Templeton Foundation | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Pedro Escudero | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual Partners GP LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual LO Equity Master Fund LP | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA1 LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Capital Management LLC | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 7, 2026 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | State Street Corporation | 2.06M | 5.2% | SCHEDULE 13G ↗ |
| May 1, 2026 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Vanguard Portfolio Management | 2.59M | 6.4% | SCHEDULE 13G ↗ |
| May 1, 2026 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Vanguard Capital Management | 2.09M | 5.2% | SCHEDULE 13G ↗ |
| Apr 9, 2026 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Dimensional Fund Advisors LP | 2.06M | 5.1% | SCHEDULE 13G ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Eric de Armas | 1,389 | 0.0% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA2 LLC | 1.97M | 4.9% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | The John Templeton Foundation | 812,019 | 2.0% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Pedro Escudero | 2.94M | 7.3% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual Partners GP LLC | 1.97M | 4.9% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual LO Equity Master Fund LP | 1.97M | 4.9% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA1 LLC | 2.78M | 6.9% | SCHEDULE 13D/A ↗ |
| Mar 12, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Capital Management LLC | 2.78M | 6.9% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA2 LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | John Templeton Foundation | 812,019 | 1.9% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Pedro Escudero | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Partners GP LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual LO Equity Master Fund LP | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Jan 2, 2026 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Capital Management LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Renaissance Technologies Holdings Corporation | 2.14M | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Renaissance Technologies LLC | 2.14M | 5.0% | SCHEDULE 13G/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA2 LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | John Templeton Foundation | 812,019 | 1.9% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Pedro Escudero | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Partners GP LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | DOMA Perpetual LO Equity Master Fund LP | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PCRX Pacira BioSciences, Inc. | Doma Perpetual Capital Management LLC | 2.94M | 6.8% | SCHEDULE 13D/A ↗ |
| Aug 13, 2025 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Renaissance Technologies Holdings Corporation | 2.40M | 5.3% | SCHEDULE 13G ↗ |
| Aug 13, 2025 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Renaissance Technologies LLC | 2.40M | 5.3% | SCHEDULE 13G ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | DOMA2 LLC | 2.70M | 5.7% | SCHEDULE 13D ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | John Templeton Foundation | 735,549 | 1.6% | SCHEDULE 13D ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | Pedro Escudero | 2.70M | 5.7% | SCHEDULE 13D ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | Doma Perpetual Partners GP LLC | 2.70M | 5.7% | SCHEDULE 13D ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | DOMA Perpetual LO Equity Master Fund LP | 2.70M | 5.7% | SCHEDULE 13D ↗ |
| Aug 8, 2025 | SCHEDULE 13D | PCRX Pacira BioSciences, Inc. | Doma Perpetual Capital Management LLC | 2.70M | 5.7% | SCHEDULE 13D ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Joe M. Thomson | 601,668 | 1.3% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Pacer Advisors, Inc. | 601,668 | 1.3% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Pacer US Small Cap Cash Cows Growth Leaders ETF | 22,134 | 0.1% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G/A (amended) | PCRX Pacira BioSciences, Inc. | Pacer US Small Cap Cash Cows ETF | 579,534 | 1.2% | SCHEDULE 13G/A ↗ |
| May 2, 2025 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Joe M. Thomson | 3.26M | 6.9% | SCHEDULE 13G ↗ |
| May 2, 2025 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Pacer Advisors, Inc. | 3.26M | 6.9% | SCHEDULE 13G ↗ |
| May 2, 2025 | SCHEDULE 13G | PCRX Pacira BioSciences, Inc. | Pacer US Small Cap Cash Cows Growth Leaders ETF | 3,419 | 0.0% | SCHEDULE 13G ↗ |
Full history on every feed is part of Premium. Premium loads older rows, up to 10,000, and CSV downloads.
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances